Onera Health
Generated 5/9/2026
Executive Summary
Onera Health is a Dutch digital health and medical device company pioneering a patch-based, wire-free polysomnography (PSG) system for at-home sleep diagnostics. Founded in 2016 and headquartered in Eindhoven, the company addresses the growing demand for convenient, clinical-grade sleep testing, aiming to replace traditional, cumbersome sleep lab studies. Onera's solution leverages a novel wearable patch that captures key sleep metrics without the need for wires or specialized facilities, improving patient comfort and access while maintaining diagnostic accuracy. With a focus on scalability and user experience, Onera is positioned to capture a significant share of the expanding sleep diagnostics market, which is driven by rising prevalence of sleep disorders such as sleep apnea and increasing preference for home-based testing.
Upcoming Catalysts (preview)
- Q3 2026FDA Clearance for Onera's PSG System55% success
- Q4 2026Strategic Partnership with Major U.S. Sleep Clinic Network45% success
- H1 2027Reimbursement Code Approval for Home-Based PSG in Key European Markets60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)